A carregar...
Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
INTRODUCTION: Psoriasis is an immune-mediated inflammatory skin disorder, which follows a chronic course. Apremilast is a novel phosphodiesterase 4 (PDE4) inhibitor, approved by US-FDA for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. A majority of the data related to...
Na minha lista:
| Publicado no: | Indian J Dermatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640799/ https://ncbi.nlm.nih.gov/pubmed/33165422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_194_19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|